Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →

2023 HERO Appendix A: NASA Human Research Program Omnibus Opportunity

Active
NNJ23ZSA001N-OMNIBUSGrant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

National Aeronautics And Space Administration → Human Exploration And Operations Mission DirectorateView Agency

NAICS

N/A

Place of Performance

Not specified

Set-Aside

NONE

Documents

(8)

2023+HERO+NRA+Overview+Final.pdf

PDF

2022+HERO+NRA+Appendix+A+Final+Amended.pdf

PDF

Pre-Proposers+Briefing+2021+A+-+Dec+2022.pdf

PDF

Pre-Proposal+Conference+HERO+2023+A.pdf

PDF

FAQ+OMNIBUS+20230403.pdf

PDF

2023+HERO+A+Amendment+1+20221201.pdf

PDF

2023+HERO+Appendix+A+Preproposers+conf+QA+update+v2.pdf

PDF

2022+HERO+DAPR-Guidelines+Update+v2.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyNational Aeronautics And Space Administration → Human Exploration And Operations Mission Directorate
Contacts1 person available
OfficeUS
Organization / Agency
National Aeronautics And Space Administration → Human Exploration And Operations Mission Directorate
View Agency Profile
Office AddressUS
Contacts
Shasta Britt Contract Specialist

Full Description

Show more
OVERVIEW
Validity Period: November 30, 2022 – November 29, 2023



REFER TO APPENDICES FOR SPECIFIC OPPORTUNITY DUE DATES
For Grants.gov reference the Catalog of Federal Domestic Assistance (CFDA) Number: 43.003
Human Exploration Research Opportunities

Page 2 of 71
Table of Contents A. EXECUTIVE SUMMARY .................................................................................................................................... 5 B. HUMAN RESEARCH PROGRAM ...................................................................................................................... 6 B.1. BACKGROUND ................................................................................................................................... 6 B.2. GOAL AND SPECIFIC OBJECTIVES ..................................................................................................... 7 C. SOLICITATION AND AWARD INFORMATION ............................................................................................ 8 C.1. PROPOSAL SOLICITATION PROCESS .................................................................................................. 8 C.2. SOLICITED RESEARCH OPPORTUNITIES ............................................................................................ 8 C.3. AWARD INFORMATION ...................................................................................................................... 9 C.4. AVAILABILITY OF FUNDS FOR AWARD ............................................................................................. 9 C.5. ADDITIONAL FUNDING RESTRICTIONS ............................................................................................ 10 D.1. EDUCATION AND PUBLIC OUTREACH ............................................................................................. 12 D.2. VERTEBRATE ANIMAL AND HIGHER ORDER CEPHALOPOD SECTION (VACS) .............................. 12 D.3. SAMPLE SIZE SPECIFICATION GUIDELINES FOR HRP RESEARCH STUDIES .................................... 12 D.4. NASA SAFETY POLICY ................................................................................................................... 13 D.5. HUMAN GENETIC RESEARCH .......................................................................................................... 13 D.6. CONSIDERATION OF SEX AS A BIOLOGICAL VARIABLE .................................................................. 14 D.7. SOFTWARE SHARING POLICY .......................................................................................................... 14 D.8. OTHER CONSIDERATIONS ............................................................................................................... 15 E. ELIGIBILITY INFORMATION ........................................................................................................................ 17 E.1. ELIGIBILITY OF APPLICANTS .............................................